These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20542809)

  • 1. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
    Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
    EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
    Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries.
    Pendyala L; Yin X; Li J; Shinke T; Xu Y; Chen JP; King SB; Colley K; Goodchild T; Chronos N; Hou D
    EuroIntervention; 2010 May; 6(1):126-33. PubMed ID: 20542808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
    Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
    Huang C; Zhao J; Zhu Y
    J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
    Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
    Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
    Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model.
    Deux JF; Meddahi-Pellé A; Le Blanche AF; Feldman LJ; Colliec-Jouault S; Brée F; Boudghène F; Michel JB; Letourneur D
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1604-9. PubMed ID: 12377737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
    Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells.
    Zeller I; Knoflach M; Seubert A; Kreutmayer SB; Stelzmüller ME; Wallnoefer E; Blunder S; Frotschnig S; Messner B; Willeit J; Debbage P; Wick G; Kiechl S; Laufer G; Bernhard D
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1733-40. PubMed ID: 20595649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
    Huang C; Zhou M; Zheng X
    J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
    Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemically modified dextran inhibits smooth muscle cell growth in vitro and intimal in stent hyperplasia in vivo.
    Deux JF; Prigent-Richard S; d'Angelo G; Feldman LJ; Puvion E; Logeart-Avramoglou D; Pellé A; Boudghène FP; Michel JB; Letourneur D
    J Vasc Surg; 2002 May; 35(5):973-81. PubMed ID: 12021714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A successful experimental model for intimal hyperplasia prevention using a resveratrol-delivering balloon.
    Tolva V; Mazzola S; Zerbi P; Casana R; Albertini M; Calvillo L; Selmin F; Cilurzo F
    J Vasc Surg; 2016 Mar; 63(3):788-94. PubMed ID: 25446284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
    Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
    Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.